“The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. In moving to Mexico, Celltex enters a country where stem cell research is not as heavily regulated as in the U.S, though a facility is required to have an International Health Department Permit (COFEPRIS). The permit allocates the use of stem-cell types beyond those in the U.S.”
Related posts:
Pew Poll: More Than 1 In 4 Americans Believe Government Is The Enemy
Facebook won’t reward hacker who exposed security flaw in Zuckerberg’s profile
Honduran Man Killed Himself After Being Separated From Family at U.S. Border
Security video shows Iowa cops beating mother in front of infant daughter
Former Fed officials lament taxpayers' inability to see necessity of bank bailouts
Venezuela's newest shortage: breast implants
First Bitcoin Hedge Fund Launches From Malta
H.K. issues Vietnam travel warning after mobs torch Chinese factories
German prosecutors rummage through nursing homes in search of ex-Nazis
Leaked Adult Friend Finder user database still online
US troops invade Syria, kill ISIS commander Abu Sayyaf
Police Officer Shoots, Pepper Sprays Squirrel Inside Dollar Store
California To Create A 'Ministry of Truth' To Combat Fake News
American Farm Bureau calls for end to federal ban on hemp
Bumpy year drags U.S. IPO listings back to 2009 levels